IND Swift Laboratories Ltd
NSE:INDSWFTLAB

Watchlist Manager
IND Swift Laboratories Ltd Logo
IND Swift Laboratories Ltd
NSE:INDSWFTLAB
Watchlist
Price: 107.52 INR -1.92%
Market Cap: ₹8.8B

Operating Margin

-3.7%
Current
Declining
by 23.1%
vs 3-y average of 19.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-3.7%
=
Operating Income
₹-304.5m
/
Revenue
₹8.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-3.7%
=
Operating Income
₹-304.5m
/
Revenue
₹8.2B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
IND Swift Laboratories Ltd
NSE:INDSWFTLAB
8.9B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
530.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
212.8B GBP
Loading...
CH
Novartis AG
SIX:NOVN
222.3B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
267.6B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.1B USD
Loading...
FR
Sanofi SA
PAR:SAN
97.2B EUR
Loading...

Market Distribution

Lower than 83% of companies in India
Percentile
17th
Based on 5 437 companies
17th percentile
-3.7%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

IND Swift Laboratories Ltd
Glance View

Market Cap
8.8B INR
Industry
Pharmaceuticals

Ind-Swift Laboratories Ltd. engages in the manufacture, development, and market of pharmaceutical ingredients. The company is headquartered in Chandigarh, Chandigarh. The company went IPO on 2002-03-15. The firm operates through the bulk drugs and pharmaceuticals segment. Its business includes Active Pharmaceutical Ingredients (APIs), Advanced Intermediates, and Contract Research and Manufacturing Services (CRAMS). The firm has a product portfolio of approximately 12 therapeutic segments. The company is manufacturing APIs of complex therapies namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Antimigraine, Parkinson’s Multidisciplinary skills Synthetic Medicinal Chemistry Custom Synthesis Process R&D cGMP Manufacturing Analytical Development Regulatory Support Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence and Bone Resorption Inhibitor. The Company’s products and services include API products, custom chemicals, and impurities. The firm manufacturing facilities are at Derabassi and Jammu Kashmir.

INDSWFTLAB Intrinsic Value
152.27 INR
Undervaluation 29%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-3.7%
=
Operating Income
₹-304.5m
/
Revenue
₹8.2B
What is IND Swift Laboratories Ltd's current Operating Margin?

The current Operating Margin for IND Swift Laboratories Ltd is -3.7%, which is below its 3-year median of 19.4%.

How has Operating Margin changed over time?

Over the last 3 years, IND Swift Laboratories Ltd’s Operating Margin has decreased from 5.7% to -3.7%. During this period, it reached a low of -7.4% on Mar 31, 2025 and a high of 92.5% on Dec 31, 2024.

Back to Top